Startup boasting 'gobstopper-style' vaccine delivery draws big partnerships — and backing from Adjuvant Capital
For as long as a prime-boost vaccine regimen — a model that’s been front and center in the fight against Covid-19 — has been deployed, scientists have been looking for ways to compress multiple doses into a single shot.
“Minimizing the touch points with patients is something that everyone’s always wanted,” said Glenn Rockman, managing partner and founder of public health-focused VC firm Adjuvant Capital.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 113,300+ biopharma pros reading Endpoints daily — and it's free.